Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP183451.RAZaDu2xW51vmyE9jXgljtgSie1PZDQavnkPRLdDa1b4o130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP183451.RAZaDu2xW51vmyE9jXgljtgSie1PZDQavnkPRLdDa1b4o130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP183451.RAZaDu2xW51vmyE9jXgljtgSie1PZDQavnkPRLdDa1b4o130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP183451.RAZaDu2xW51vmyE9jXgljtgSie1PZDQavnkPRLdDa1b4o130_provenance.
- NP183451.RAZaDu2xW51vmyE9jXgljtgSie1PZDQavnkPRLdDa1b4o130_assertion description "[l-asparaginase-containing regimens such as SMILE (steroid, methotrexate, ifosfamide, l-asparaginase, and etoposide) are effective for ENKL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP183451.RAZaDu2xW51vmyE9jXgljtgSie1PZDQavnkPRLdDa1b4o130_provenance.
- NP183451.RAZaDu2xW51vmyE9jXgljtgSie1PZDQavnkPRLdDa1b4o130_assertion evidence source_evidence_literature NP183451.RAZaDu2xW51vmyE9jXgljtgSie1PZDQavnkPRLdDa1b4o130_provenance.
- NP183451.RAZaDu2xW51vmyE9jXgljtgSie1PZDQavnkPRLdDa1b4o130_assertion SIO_000772 23768637 NP183451.RAZaDu2xW51vmyE9jXgljtgSie1PZDQavnkPRLdDa1b4o130_provenance.
- NP183451.RAZaDu2xW51vmyE9jXgljtgSie1PZDQavnkPRLdDa1b4o130_assertion wasDerivedFrom befree-20140225 NP183451.RAZaDu2xW51vmyE9jXgljtgSie1PZDQavnkPRLdDa1b4o130_provenance.
- NP183451.RAZaDu2xW51vmyE9jXgljtgSie1PZDQavnkPRLdDa1b4o130_assertion wasGeneratedBy ECO_0000203 NP183451.RAZaDu2xW51vmyE9jXgljtgSie1PZDQavnkPRLdDa1b4o130_provenance.
- befree-20140225 importedOn "2014-02-25" NP183451.RAZaDu2xW51vmyE9jXgljtgSie1PZDQavnkPRLdDa1b4o130_provenance.